FIELD: medicine.
SUBSTANCE: what is offered a method for prediction of a clinical course of autoimmune pemphigus including biopsy of an intact skin differing by the fact that a biopsy material is examined by direct ELISA; it involves determining a localisation pattern of fixed immunoglobulin class G which is when observed as granular depositions in intracellular spaces enables to predict a severe course of pemphigus. Grid-like immunoglobulin G found in intercellular spaces provides predicting a favourable course of pemphigus.
EFFECT: more accurate prediction of clinical current of autoimmune pemphigus and reduced potential complications.
2 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF VARIABILITY OF PEMPHIGUS CLINICAL FORM | 2008 |
|
RU2386400C1 |
METHOD OF DIAGNOSTICS OF AUTOIMMUNE VIOLENT DERMATOSES | 2008 |
|
RU2352947C1 |
METHOD FOR DIAGNOSING PEMPHIGUS | 1994 |
|
RU2097768C1 |
METHOD FOR PREDICTING COURSE OF ISOLATED FORM OF ACANTHOLYTIC PERVASIVE CAVITY | 2018 |
|
RU2688209C1 |
METHOD OF SAMPLE PREPARATION OF SAMPLES FOR IMMUNOFLUORESCENT RESEARCH IN DIAGNOSIS OF HAILEY-HAILEY DISEASE | 2015 |
|
RU2624501C2 |
METHOD FOR DIAGNOSING PEMPHIGUS | 0 |
|
SU1748070A1 |
ACANTHOLYTIC PEMPHIGUS TREATMENT METHOD | 2009 |
|
RU2391984C1 |
METHOD FOR ESTIMATING PEMPHIGUS TREATMENT EFFECTIVENESS | 2006 |
|
RU2316005C1 |
METHOD FOR ESTIMATING PEMPHIGUS CLINICAL COURSE SEVERITY DEGREE | 2006 |
|
RU2316006C1 |
APPLICATION OF SELECTIVE IMMUNOSORBENT FOR REMOVAL OF ANTIBODIES TO TYPE 3 DESMOGLEIN FROM BLOOD SERUM OF PATIENTS WITH VESICULAR FEVER | 2016 |
|
RU2627652C1 |
Authors
Dates
2011-09-20—Published
2010-06-03—Filed